Now, as we embark on the second quarter of the 21st century, what could Rhode Island look like in 2050? The staff at The ...
PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
The Cash Price Laboratory service is set to launch on Jan. 14. UNC Health Southeastern Main Laboratory hours are Monday ...
From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...
Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...
For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
Health and Me on MSN
WHO approves two COVID-19 rapid antigen tests, check the details here
SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...
WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results